Thus, patients with heterozygous CUL3 pathogenic variants are more likely to develop severe hyperkalemia, metabolic acidosis, hypertension, and growth impairment at an early stage than individuals carrying recessive KLHL3, dominant KLHL3, WNK4, or WNK1 pathogenic variants [6]. This evidence concerns the gene KLHL3 and metabolic acidosis.